Business Description
Orient Europharma Co Ltd
ISIN : TW0004120001
Description
Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.45 | |||||
| Equity-to-Asset | 0.45 | |||||
| Debt-to-Equity | 0.82 | |||||
| Debt-to-EBITDA | 23.01 | |||||
| Interest Coverage | 0.12 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.12 | |||||
| Beneish M-Score | -2.26 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -2.7 | |||||
| 3-Year EBITDA Growth Rate | -16.3 | |||||
| 3-Year EPS without NRI Growth Rate | -91.4 | |||||
| 3-Year FCF Growth Rate | 47 | |||||
| 3-Year Book Growth Rate | 20.6 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 37.44 | |||||
| 9-Day RSI | 47.79 | |||||
| 14-Day RSI | 52.72 | |||||
| 3-1 Month Momentum % | 0.1 | |||||
| 6-1 Month Momentum % | -0.2 | |||||
| 12-1 Month Momentum % | 20.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | |||||
| Quick Ratio | 0.89 | |||||
| Cash Ratio | 0.57 | |||||
| Days Inventory | 168.2 | |||||
| Days Sales Outstanding | 58.41 | |||||
| Days Payable | 35.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.88 | |||||
| 3-Year Dividend Growth Rate | -12.6 | |||||
| Forward Dividend Yield % | 1.88 | |||||
| 5-Year Yield-on-Cost % | 1.88 | |||||
| Shareholder Yield % | 9.07 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 47.05 | |||||
| Operating Margin % | 0.3 | |||||
| Net Margin % | -6.47 | |||||
| FCF Margin % | -5.04 | |||||
| ROE % | -6.19 | |||||
| ROA % | -2.44 | |||||
| ROIC % | 0.22 | |||||
| 3-Year ROIIC % | 4.76 | |||||
| ROC (Joel Greenblatt) % | -0.45 | |||||
| ROCE % | -0.29 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 22.83 | |||||
| PS Ratio | 1.06 | |||||
| PB Ratio | 0.9 | |||||
| Price-to-Tangible-Book | 0.91 | |||||
| EV-to-EBIT | -334.74 | |||||
| EV-to-EBITDA | 41.43 | |||||
| EV-to-Revenue | 1.74 | |||||
| EV-to-FCF | -34.43 | |||||
| Price-to-GF-Value | 1.49 | |||||
| Price-to-Projected-FCF | 9.93 | |||||
| Price-to-Median-PS-Value | 1.25 | |||||
| Earnings Yield (Greenblatt) % | -0.3 | |||||
| FCF Yield % | -4.79 | |||||
| Forward Rate of Return (Yacktman) % | -30.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Orient Europharma Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 4,391.301 | ||
| EPS (TTM) (NT$) | -3.27 | ||
| Beta | -0.27 | ||
| 3-Year Sharpe Ratio | 0.54 | ||
| 3-Year Sortino Ratio | 0.98 | ||
| Volatility % | 18.06 | ||
| 14-Day RSI | 52.72 | ||
| 14-Day ATR (NT$) | 2.118144 | ||
| 20-Day SMA (NT$) | 52.7825 | ||
| 12-1 Month Momentum % | 20.07 | ||
| 52-Week Range (NT$) | 40.3 - 60.7 | ||
| Shares Outstanding (Mil) | 86.75 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Orient Europharma Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Orient Europharma Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Orient Europharma Co Ltd Frequently Asked Questions
What is Orient Europharma Co Ltd(ROCO:4120)'s stock price today?
The current price of ROCO:4120 is NT$53.30. The 52 week high of ROCO:4120 is NT$60.70 and 52 week low is NT$40.30.
When is next earnings date of Orient Europharma Co Ltd(ROCO:4120)?
The next earnings date of Orient Europharma Co Ltd(ROCO:4120) is .
Does Orient Europharma Co Ltd(ROCO:4120) pay dividends? If so, how much?
The Dividend Yield %  of Orient Europharma Co Ltd(ROCO:4120) is 1.88% (As of Today), Highest Dividend Payout Ratio of Orient Europharma Co Ltd(ROCO:4120) was 1.09. The lowest was 0.34. And the median was 0.65. The  Forward Dividend Yield % of Orient Europharma Co Ltd(ROCO:4120) is 1.88%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers